Abstract: The present invention relates to the use of soluble CD163 as a prognostic marker for the assessment of the risk for contracting a disorder, in particular for contracting diabetes and/or a liver disorder. The invention also relates to the use of CD163 as a prognostic marker for assessing lifetime expectancy.
Type:
Application
Filed:
October 12, 2010
Publication date:
October 4, 2012
Applicants:
Region Midjylland, Aarhus Universitet
Inventors:
Søren Moestrup, Ruth Frikke-Schmidt, Anne Tybjaerg-Hansen, Holger J. Møller